Hard to Treat Diseases (Hard to Treat Diseases) Long-Term Capital Lease Obligation : $0.00 Mil (As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Long-Term Capital Lease Obligation?

Hard to Treat Diseases's Long-Term Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Long-Term Capital Lease Obligation Historical Data

The historical data trend for Hard to Treat Diseases's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Long-Term Capital Lease Obligation Chart

Hard to Treat Diseases Annual Data

Trend

Long-Term Capital Lease Obligation

Hard to Treat Diseases Quarterly Data

Long-Term Capital Lease Obligation

Hard to Treat Diseases (OTCPK:HTDS) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Hard to Treat Diseases Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines